PT86332A - Pferde-gamma-interferon - Google Patents

Pferde-gamma-interferon

Info

Publication number: PT86332A
Authority: PT; Portugal
Prior art keywords: gamma; eqifn; interferon; horse; polypeptide
Prior art date: 1986-12-10

Application number

PT86332A

Other languages

German (de)

English (en)

Other versions

PT86332B (pt

Inventor

Rudolf Hauptmann

Adolf Himmler

Peter Stwetly

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-12-10

Filing date

1987-12-10

Publication date

1988-01-01

1987-12-10 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

1988-01-01 Publication of PT86332A publication Critical patent/PT86332A/pt

1990-11-07 Publication of PT86332B publication Critical patent/PT86332B/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/249—Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

PT86332A 1986-12-10 1987-12-10 Processo para a preparacao de interferao gama de cavalo, de adn que codifica para este interferao e de anticorpos monoclonais contra o mesmo, como de agentes terapeuticos contendo estes produtos PT86332B (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19863642096 DE3642096A1 (de)	1986-12-10	1986-12-10	Pferde-(gamma)-interferon

Publications (2)

Publication Number	Publication Date
PT86332A true PT86332A (de)	1988-01-01
PT86332B PT86332B (pt)	1990-11-07

Family

ID=6315829

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT86332A PT86332B (pt)	1986-12-10	1987-12-10	Processo para a preparacao de interferao gama de cavalo, de adn que codifica para este interferao e de anticorpos monoclonais contra o mesmo, como de agentes terapeuticos contendo estes produtos

Country Status (20)

Country	Link
US (1)	US5602010A (pt)
EP (1)	EP0271824B1 (pt)
JP (3)	JPS63233794A (pt)
KR (1)	KR880007568A (pt)
AT (1)	ATE91722T1 (pt)
AU (1)	AU616873B2 (pt)
CA (1)	CA1339776C (pt)
DE (2)	DE3642096A1 (pt)
DK (1)	DK170054B1 (pt)
ES (1)	ES2058094T3 (pt)
FI (1)	FI99116C (pt)
HU (1)	HU213566B (pt)
IE (1)	IE60404B1 (pt)
IL (1)	IL84780A (pt)
NO (1)	NO180239C (pt)
NZ (1)	NZ222856A (pt)
PH (1)	PH30889A (pt)
PT (1)	PT86332B (pt)
SU (1)	SU1701114A3 (pt)
ZA (1)	ZA879245B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO811118L (no)	1980-04-03	1981-10-05	Biogen Nv	Dna-sekvenser, rekombinante dna-molekyler og fremgangsmaate ved fremstilling av polypeptider
US5272263A (en) *	1989-04-28	1993-12-21	Biogen, Inc.	DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US6307025B1 (en)	1989-04-28	2001-10-23	Biogen, Inc.	VCAM fusion proteins and DNA coding therefor
US7049102B1 (en)	1989-09-22	2006-05-23	Board Of Trustees Of Leland Stanford University	Multi-gene expression profile
GB9414752D0 (en) *	1994-07-21	1994-09-07	Q One Biotech Ltd	Feline gamma-interferon
GB2291645A (en) *	1994-07-21	1996-01-31	Q One Biotech Ltd	Equine gamma-interferon
JP4220235B2 (ja) *	2000-11-03	2009-02-04	インターシアセラピューティクス，インコーポレイティド	短期及び長期の薬剤薬量決定のための方法
EP1536839B1 (en) *	2001-11-09	2010-09-15	Intarcia Therapeutics, Inc	Combination therapy comprising omega-interferon for treating infection with hepatitis c virus or yellow fever virus
US7731947B2 (en)	2003-11-17	2010-06-08	Intarcia Therapeutics, Inc.	Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en)	2005-02-03	2006-08-10	Alza Corporation	Solvent/polymer solutions as suspension vehicles
DE602007009377D1 (de)	2006-05-30	2010-11-04	Intarcia Therapeutics Inc	Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
EP2359808B1 (en)	2006-08-09	2013-05-22	Intarcia Therapeutics, Inc	Osmotic delivery systems and piston assemblies
AU2008244523B2 (en)	2007-04-23	2012-02-16	Intarcia Therapeutics, Inc.	Suspension formulations of insulinotropic peptides and uses thereof
DK2240155T3 (da)	2008-02-13	2012-09-17	Intarcia Therapeutics Inc	Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
LT2462246T (lt)	2009-09-28	2017-11-27	Intarcia Therapeutics, Inc	Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en)	2015-06-03	2021-02-23	Intarcia Therapeutics, Inc.	Implant placement and removal systems
EP3458084B1 (en)	2016-05-16	2020-04-01	Intarcia Therapeutics, Inc	Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
KR20190104039A (ko)	2017-01-03	2019-09-05	인타르시아 세라퓨틱스 인코포레이티드	Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE88622C (pt) *
ZA811368B (en) *	1980-03-24	1982-04-28	Genentech Inc	Bacterial polypedtide expression employing tryptophan promoter-operator
EP0088540A3 (en) *	1982-02-22	1984-10-17	Biogen, Inc.	Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IE54592B1 (en) *	1982-03-08	1989-12-06	Genentech Inc	Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
DE3247922A1 (de) *	1982-12-24	1984-06-28	Boehringer Ingelheim International GmbH, 6507 Ingelheim	Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
JPS60118196A (ja) *	1983-11-30	1985-06-25	Takeda Chem Ind Ltd	インタ−フェロンの製造法
US4666865A (en) *	1984-01-13	1987-05-19	Centocor, Inc.	Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
DE3414831A1 (de) *	1984-04-19	1985-10-31	Hoechst Ag, 6230 Frankfurt	Herstellung von polypeptiden mit human-gammainterferon-aktivitaet
FI90990C (fi) *	1984-12-18	1994-04-25	Boehringer Ingelheim Int	Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
US4689224A (en) *	1985-10-07	1987-08-25	Neogen Corporation	Method for administering vaccines containing equine leukokines and compositions therefor
DE3607835A1 (de) *	1986-03-10	1987-09-24	Boehringer Ingelheim Int	Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
CA1340698C (en) *	1986-07-25	1999-08-10	Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo	Preparation and uses of interferon-gamma
US4908432A (en) *	1987-01-09	1990-03-13	New York University	Novel polypeptide having gamma-interferon activity

1986
- 1986-12-10 DE DE19863642096 patent/DE3642096A1/de not_active Ceased
1987
- 1987-12-08 AU AU82233/87A patent/AU616873B2/en not_active Ceased
- 1987-12-09 CA CA000553890A patent/CA1339776C/en not_active Expired - Fee Related
- 1987-12-09 SU SU874203834A patent/SU1701114A3/ru active
- 1987-12-09 EP EP87118264A patent/EP0271824B1/de not_active Expired - Lifetime
- 1987-12-09 ES ES87118264T patent/ES2058094T3/es not_active Expired - Lifetime
- 1987-12-09 NZ NZ222856A patent/NZ222856A/xx unknown
- 1987-12-09 DE DE8787118264T patent/DE3786649D1/de not_active Expired - Fee Related
- 1987-12-09 NO NO875136A patent/NO180239C/no unknown
- 1987-12-09 IE IE334287A patent/IE60404B1/en not_active IP Right Cessation
- 1987-12-09 DK DK645887A patent/DK170054B1/da not_active IP Right Cessation
- 1987-12-09 ZA ZA879245A patent/ZA879245B/xx unknown
- 1987-12-09 AT AT87118264T patent/ATE91722T1/de not_active IP Right Cessation
- 1987-12-09 HU HU875549A patent/HU213566B/hu not_active IP Right Cessation
- 1987-12-10 FI FI875427A patent/FI99116C/fi not_active IP Right Cessation
- 1987-12-10 IL IL84780A patent/IL84780A/xx not_active IP Right Cessation
- 1987-12-10 JP JP62313130A patent/JPS63233794A/ja active Pending
- 1987-12-10 PH PH36200A patent/PH30889A/en unknown
- 1987-12-10 PT PT86332A patent/PT86332B/pt not_active IP Right Cessation
- 1987-12-10 KR KR870014068A patent/KR880007568A/ko not_active Application Discontinuation
1994
- 1994-06-17 US US08/263,214 patent/US5602010A/en not_active Expired - Fee Related
- 1994-12-12 JP JP6307980A patent/JPH07258294A/ja active Pending
- 1994-12-12 JP JP6307981A patent/JPH07250690A/ja active Pending

Also Published As

Publication number	Publication date
JPS63233794A (ja)	1988-09-29
NO875136L (no)	1988-06-13
NO875136D0 (no)	1987-12-09
FI875427A (fi)	1988-06-11
KR880007568A (ko)	1988-08-27
IL84780A (en)	1992-11-15
DE3642096A1 (de)	1988-06-16
FI99116C (fi)	1997-10-10
DK645887D0 (da)	1987-12-09
IE873342L (en)	1988-06-10
DK645887A (da)	1988-06-11
AU616873B2 (en)	1991-11-14
AU8223387A (en)	1988-06-30
US5602010A (en)	1997-02-11
NO180239B (no)	1996-12-02
FI99116B (fi)	1997-06-30
DK170054B1 (da)	1995-05-08
CA1339776C (en)	1998-03-24
ZA879245B (en)	1989-08-30
ES2058094T3 (es)	1994-11-01
NO180239C (no)	1997-03-12
IL84780A0 (en)	1988-05-31
HU213566B (en)	1997-08-28
EP0271824A3 (en)	1989-05-24
PT86332B (pt)	1990-11-07
EP0271824A2 (de)	1988-06-22
NZ222856A (en)	1991-11-26
PH30889A (en)	1997-12-23
HUT46066A (en)	1988-09-28
DE3786649D1 (de)	1993-08-26
JPH07250690A (ja)	1995-10-03
FI875427A0 (fi)	1987-12-10
ATE91722T1 (de)	1993-08-15
SU1701114A3 (ru)	1991-12-23
JPH07258294A (ja)	1995-10-09
EP0271824B1 (de)	1993-07-21
IE60404B1 (en)	1994-07-13

Publication	Publication Date	Title
ATE91722T1 (de)	1993-08-15	Pferde-gamma-interferon.
DZ467A1 (fr)	2004-09-13	Interferon immunitaire urbain.
DK638887D0 (da)	1987-12-04	Syntetiske polypeptider og deres anvendelse til diagnosticering
NZ218332A (en)	1993-04-28	Il-4(interleukin-4), recombinant production, dna, vectors and pharmaceutical composition
NO863000D0 (no)	1986-07-25	Fusjonsproteiner og fremgangsmaate til fremstilling derav.
DK491487A (da)	1988-03-20	Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme
ATE109205T1 (de)	1994-08-15	Verbesserung der ausbeute bei der sekretion von disulfidverbrückten proteinen.
IL81018A (en)	1992-03-29	Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
ES8704207A1 (es)	1987-03-16	Procedimiento para preparar una molecula de adn
DE3881023D1 (de)	1993-06-17	Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
GB2171703B (en)	1989-11-15	Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
DK27097A (da)	1997-03-13	Minactivin og fremgangsmåde til fremstilling deraf

Legal Events

Date	Code	Title	Description
2000-01-31	MM3A	Annulment or lapse	Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19990930

Date

Code

Title

Description

2000-01-31

MM3A

Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19990930